The present disclosure relates to a prosthesis such as a stent graft for deployment in a body vessel, including at arterial branching points.
A stent graft is commonly used to reinforce a weakened area in an artery such as an aneurysm. Blood pressure, among other factors, can cause this weakened area to bulge over time. The bulged area can eventually enlarge and rupture if not treated. The stent graft is designed to seal tightly with the artery above and below the aneurysm to allow the blood to flow through the stent graft without causing the weakened area to bulge. When the aneurysm is located in a region of a body lumen adjacent to a branch vessel, the stent graft may need to accommodate the opening to that vessel so that blood flow is not blocked or obstructed. For example, a stent graft may include fenestrations, branches, bare stents and the like to allow blood to flow into a branch vessel.
The invention is directed to a stent-graft having at least one scallop or cut out in an edge of the graft. The scallop has three sides including a lateral side having a lateral edge. A scallop support structure at least partially conforms to the perimeter of the scallop and has an undulating base that extends below the edge of the scallop and has peaks and valleys. The peaks abut the edge of the scallop and the valleys extend below the edge of the scallop. The scallop support structure has at least two substantially longitudinal perimeter support sections, and the undulating lateral base extends between the at least two substantially longitudinal perimeter support sections. The undulating lateral base has at least two undulations. The two perimeter support sections bound the longitudinal sides. Further aspects of the invention are described here with reference to the drawings.
The drawings described herein are for illustration purposes only and are not intended to limit the scope of the present disclosure in any way.
In the present application, the term “proximal” refers to a direction that is farthest away from the operator when referring to a delivery device, while the term “distal” refers to a direction that is generally closest to the operator using the delivery device. The distal end of the delivery device is that portion of the device that is intended to remain outside of a patient during a procedure. When referring to the prosthesis itself relative to the delivery device, the proximal end of the prosthesis is that part of the prosthesis nearest the proximal end of the delivery device and the distal end of the prosthesis is that end that is closest to the distal end of the delivery device.
In one example, the stent structure 12 may include a self-expandable proximal sealing stent 22 to engage a vessel wall when deployed adjacent to a weakened area of the body lumen, or aneurysm. The stent structure 12 may also include one or a series of stents 24 such as z-stents or the like located distal to the proximal sealing stent 22 as shown in
Stents at one or both ends of the graft material may be located on the internal surface of at least a portion of the stent graft to provide a smooth outside sealing surface of the graft material against the vessel wall adjacent to the aneurysm as shown in
The stent graft 10 includes a proximal end 18 and a distal end 20. As shown in
Referring to
In one example, scallop 48 may be adjacent to the proximal edge 42. As shown in
Referring back to
The proximal stent 22 may include a plurality of first curved struts 32 and a plurality of second curved struts 34. The first and second curved struts 32 and 34 are alternately arranged to form a generally elliptical or ring-like configuration. The first and second curved struts 32 and 34 are connected at their opposing ends or apices 36 so that one first curved strut 32 and one adjacent second curved strut 34 form a closed cell 38 having an enlarged middle portion and opposing narrowed portions. The closed cells 38 are connected to at least one point along the sides 40 of the first and second curved struts 32 and 34 to form a ring-like configuration. The apices 36 of the first and second curved struts 32 and 34 may be configured to have generally smooth rounded edges to avoid damaging the vessel lumen wall.
Referring back to
The opposing longitudinal edges 52 of the scallop 48 of the tubular graft material 14 can be stitched by sutures 16 to the first and second curved struts 32 and 34 along at least part of the length of the first and second curved struts 32 and 34. Therefore, the opposing longitudinal edges 52 can conform to a part of the shape of the first and second curved struts 32 and 34.
As described in more detail below, the scallop 48 formed in the tubular graft material 14 may be supported by one or more structures, including a base strut 56 and a support structure 60 that provides additional support for scallop 48. A base strut 56 may be disposed along the lateral edge 50 of the scallop 48. The base strut 56 may be secured to the stent structure 12 and/or the tubular graft material 14 by any known attachment mechanisms. For example, the base strut 56 may be attached to the stent structure 12 and/or the tubular graft material 14 by stitching, gluing, welding, or sutures. In one example, the base strut 56 is sewn along the lateral edge 50 of the scallop 48 to connect the support structure 60 and the tubular graft material 14 at stitch line 15.
The stent graft 10 may further include a support structure 60 to provide additional support for the scallop 48 of the tubular graft material 14. The support structure may be located anywhere on the stent graft 10, and in one example, the support structure is located adjacent to the perimeter of the scallop 48.
The support structure 60 may have any suitable design that preferably corresponds to and/or accommodates the general shape and dimension of the scallop 48. As described below,
The support structure 60 may be secured to the stent structure 12 and/or the tubular graft material 14 by any known attachment mechanisms. For example, the support structure 60 may be attached to the stent structure 12 and/or to the tubular graft material 14 by stitching, gluing, welding, or sutures. In one example, the support structure 60 is sewn onto the graft material 14 along one or more points of the longitudinal edges 52 of scallop 48. The support structure 60 may also be sewn onto the graft material 14 just distal to the lateral edge 50 of the scallop 48.
The support structures described herein may be formed from any biocompatible material such as stainless steel, nickel-titanium alloy (nitinol), ceramic, cobalt/chromium alloys, aluminum or other biocompatible metals and/or composites or alloys such as carbon or carbon fiber. In one example, the support structures are made of stainless steel and are resilient, which allows the stent graft 10 to be delivered to a target site in a compressed configuration and to expand in a deployment configuration.
The support structure 60 (and other support structures disclosed below) may be configured to support the graft material 14. The support structure may also serve to reduce tearing or separation of the graft material 14 from the stent structure 12. In one example, the support structure 60 reinforces the scallop 48 so that blood flow forces do not tear, separate, or disfigure the graft material and/or push the graft material 14 away from or off of the stent structure 12.
In the case of balloon expandable stents, the support structure 60 (and other support structures disclosed below) may provide a more dimensionally stable scallop 48 in the tubular graft material 14, particularly when a balloon expandable stent is used as a leg or side arm extension through a branch vessel (not shown). With the support structure 60, the force of the balloon expansion is less likely to tear the graft material 14 from the stent structure 12.
The support structure 60 may be attached to the stent structure 12 or to the tubular graft material 14, or both. In one example, the lateral base 62 is disposed along the lateral edge 50 of the scallop 48, and as illustrated in
A portion of the support structure 60 may have a shape that generally conforms to the shape of at least a portion of the first or second curved struts 32 and 34 of stent structure 12. As an example shown in
The stent graft 90 includes a stent structure 12, a tubular graft material 14, and a support structure 92. Similar to the first embodiment, scallop 48 is formed in the tubular graft material 14 having a perimeter 54 including a lateral edge 50 and opposing longitudinal edges 52. At least a portion of the opposing longitudinal edges 52 extend along a portion of the first and second curved struts 32 and 34.
A base strut 56 is disposed along the lateral edge 50 of the scallop 48. The perimeter 54 of the scallop 48 is attached at one or more points to the first and second curved struts 32, 34 and the base strut 56.
The support structure 92 includes a lateral base 94 and an attaching member 96. The lateral base 94 includes one or more bent segments 98 and an apex 102 between the one or more bent segments 98 that is adjacent to the base strut 56. The attaching member 96 includes a pair of opposing struts 104 extending from the lateral base 94 and disposed generally along the longitudinal edges 52 of the scallop 48. The opposing struts 104 may be attached at one or more points along a portion of the first and second curved struts 32 and 34 of the proximal stent 22. In one example, the opposing struts 104 may also include a first segment 76 and a second segment 80 similar to the opposing struts 66 in
Similar to support structure 60, the support structure 92 may be secured to the stent structure 12 and/or the tubular graft material 14 by any known attachment mechanism. For example, the support structure 92 may be attached to the stent structure 12 and/or the tubular graft material 14 by stitching, gluing, welding, or sutures. In one example shown in
The support structure 92 may be formed from any biocompatible material such as stainless steel, nickel-titanium alloy (nitinol), ceramic, cobalt/chromium alloys, aluminum or other biocompatible metals and/or composites or alloys such as carbon or carbon fiber. In one example, the support structure 92 is made of stainless steel and is resilient, which allows the scallop 48 and the stent graft 90 to be delivered in a compressed configuration and to expand in a deployment configuration.
The opposing struts 122 each include a first segment 124 connected to the one or more bent segments 116 of the lateral base 112, and a second segment 126 connected to an end of the first segment 124. A loop 82 may be formed between the first segment 124 and the second segment 126. One or both of the second segments 126 may further include a third segment 128 connected to the second segment 126. The opposing struts may or may not be symmetrical. For example, as shown in
The support structure 110 may be attached to the stent structure 12 and/or the graft material 14. In one example, the first segments 124 may be attached to the graft material 14 along the opposing longitudinal edges 52 of the scallop 48 and/or to at least a portion of the first and second curved struts 32 and 34. The second segment 126 may be disposed along at least a portion proximal edge 42 of the tubular graft material 14. The third segment 128 may be attached along a portion of the first and second curved struts 32 and 34.
The three segments 124, 126 and/or 128 shown in
The attaching member 164 includes a pair of opposing struts 172 extending from the lateral base 162.
The setting fixture 180 shown in
The plurality of first apertures 184, second apertures 186 and third apertures 188 may have any number of openings in the plate body 182. In one example, the plurality of first apertures 184 may have 15 openings, the plurality of second apertures 186 may have 3 openings and the plurality of third apertures 188 may have 3 openings in the plate body 182.
The first apertures 184 may be used to set the shape of the lateral base of the support structure, whereas the second apertures 186 and the third apertures 188 may be used to set the two opposing struts of the attaching member of the support structure.
The support structure according to any of the embodiments in this disclosure may be formed by securing one or more wires to the plate body 182 at locations corresponding to one or more of the first, second and third apertures 184, 186, 188 to set the shape of the support structure. In one example, a single wire is used to create the support structure. The shape of the lateral base of the support structure may be set by the first apertures 184 by securing a portion of the wire to the first apertures 184 at predetermined locations. The lateral base may be set to have any shape, including a linear shape, a zig-zag shape, a single curve shape, an arc shape, a triangular shape, or a wavy shape. The lateral base can have any other shape as long as it is disposed distally of the bottom edge of the scallop 48 to provide additional support for the scallop 48. The shape of the opposing struts of the attaching member of the support structure may be set by the second and third apertures 186 and 188 by securing another portion of the wire to the second apertures 186 and the third apertures 188, respectively, at predetermined locations.
After the wire is attached to the setting fixture. 180, the wire may be subject to heat treatment to set the configuration of the support structure. After the support structure is formed, the support structure may be attached to any existing stent graft to provide additional support for a scallop 48.
It should be noted that the disclosure is not limited to the embodiment described and illustrated as examples.
This application claims the benefit of priority of U.S. Provisional Application Ser. No. 62/487,108, filed Apr. 19, 2017, and is a continuation-in-part of U.S. application Ser. No. 14/875,925, filed Oct. 6, 2015, which claims the benefit of priority of U.S. Provisional Application Ser. No. 62/064,595, filed Oct. 16, 2014, all of which are incorporated by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
4902508 | Badylak et al. | Feb 1990 | A |
4907336 | Gianturco | Mar 1990 | A |
5387235 | Chuter | Feb 1995 | A |
5591230 | Horn et al. | Jan 1997 | A |
5617878 | Taheri | Apr 1997 | A |
5653743 | Martin | Aug 1997 | A |
5709713 | Evans et al. | Jan 1998 | A |
5711969 | Patel et al. | Jan 1998 | A |
5720776 | Chuter et al. | Jan 1998 | A |
5733337 | Carr, Jr. et al. | Mar 1998 | A |
5755778 | Kleshinski | May 1998 | A |
5769882 | Fogarty et al. | Jun 1998 | A |
5782904 | White et al. | Jul 1998 | A |
5885619 | Patel et al. | Mar 1999 | A |
5906640 | Penn et al. | May 1999 | A |
5921995 | Kleshinski | Jul 1999 | A |
5955110 | Patel et al. | Sep 1999 | A |
5961548 | Shmulewitz | Oct 1999 | A |
5968096 | Whitson et al. | Oct 1999 | A |
5984955 | Wisselink | Nov 1999 | A |
6042605 | Martin | Mar 2000 | A |
6056775 | Borghi et al. | May 2000 | A |
6077296 | Shokoohi et al. | Jun 2000 | A |
6099558 | White et al. | Aug 2000 | A |
6187033 | Schmitt et al. | Feb 2001 | B1 |
6203568 | Lombardi et al. | Mar 2001 | B1 |
6206931 | Cook et al. | Mar 2001 | B1 |
6210429 | Vardi et al. | Apr 2001 | B1 |
6221102 | Baker et al. | Apr 2001 | B1 |
6261273 | Ruiz | Jul 2001 | B1 |
6287315 | Wijeratne et al. | Sep 2001 | B1 |
6287330 | Johansson et al. | Sep 2001 | B1 |
6325826 | Vardi et al. | Dec 2001 | B1 |
6334867 | Anson | Jan 2002 | B1 |
6344052 | Greenan et al. | Feb 2002 | B1 |
6395018 | Castaneda | May 2002 | B1 |
6409750 | Hyodoh et al. | Jun 2002 | B1 |
6428565 | Wisselink | Aug 2002 | B1 |
6524335 | Hartley et al. | Feb 2003 | B1 |
6558418 | Carpentier et al. | May 2003 | B2 |
6648722 | Lynders et al. | Nov 2003 | B2 |
6890340 | McGuckin, Jr. et al. | May 2005 | B2 |
6939370 | Hartley et al. | Sep 2005 | B2 |
6974471 | Van Schie et al. | Dec 2005 | B2 |
7011679 | Lauterjung | Mar 2006 | B2 |
7105020 | Greenberg et al. | Sep 2006 | B2 |
7232459 | Greenberg et al. | Jun 2007 | B2 |
7238198 | Hartley et al. | Jul 2007 | B2 |
7273459 | Desilets et al. | Sep 2007 | B2 |
7294147 | Hartley et al. | Nov 2007 | B2 |
7413573 | Hartley | Aug 2008 | B2 |
7438721 | Doig et al. | Oct 2008 | B2 |
7537606 | Hartley et al. | May 2009 | B2 |
7708771 | Chuter et al. | May 2010 | B2 |
7722657 | Hartley | May 2010 | B2 |
7803177 | Hartley et al. | Sep 2010 | B2 |
8518098 | Roeder et al. | Aug 2013 | B2 |
8926686 | King | Jan 2015 | B2 |
9060887 | Hartley et al. | Jun 2015 | B2 |
9072261 | Hartley et al. | Jul 2015 | B2 |
9095458 | Hartley et al. | Aug 2015 | B2 |
9539123 | Hartley et al. | Jan 2017 | B2 |
20020052648 | McGuckin, Jr. et al. | May 2002 | A1 |
20030088305 | Van Schie et al. | May 2003 | A1 |
20030120332 | Hartley | Jun 2003 | A1 |
20030130719 | Martin | Jul 2003 | A1 |
20030199967 | Hartley | Oct 2003 | A1 |
20030233140 | Hartley et al. | Dec 2003 | A1 |
20040073289 | Hartley | Apr 2004 | A1 |
20040082990 | Hartley | Apr 2004 | A1 |
20040098079 | Hartley et al. | May 2004 | A1 |
20040106978 | Greenberg et al. | Jun 2004 | A1 |
20040215327 | Doig et al. | Oct 2004 | A1 |
20040225349 | Thistle et al. | Nov 2004 | A1 |
20060247761 | Greenberg | Nov 2006 | A1 |
20070233222 | Roeder | Oct 2007 | A1 |
20090182411 | Irwin et al. | Jul 2009 | A1 |
20100100167 | Bortlein | Apr 2010 | A1 |
20130116775 | Roeder et al. | May 2013 | A1 |
20130131777 | Hartley | May 2013 | A1 |
20130289701 | Coghlan et al. | Oct 2013 | A1 |
20130289702 | Coghlan et al. | Oct 2013 | A1 |
20160106564 | Roeder et al. | Apr 2016 | A1 |
20170112642 | Hartley et al. | Apr 2017 | A1 |
Number | Date | Country |
---|---|---|
2 803 340 | Nov 2014 | EP |
2803340 | Nov 2014 | EP |
2000-279532 | Oct 2000 | JP |
2001-129001 | May 2001 | JP |
2002-500920 | Jan 2002 | JP |
WO 9516406 | Jun 1995 | WO |
WO 9745073 | Dec 1997 | WO |
WO 9748350 | Dec 1997 | WO |
WO 9822158 | May 1998 | WO |
WO 9836709 | Aug 1998 | WO |
WO 9853761 | Dec 1998 | WO |
WO 9929262 | Jun 1999 | WO |
WO 9939663 | Aug 1999 | WO |
WO 0067674 | Nov 2000 | WO |
WO 02067816 | Sep 2002 | WO |
WO 03034948 | May 2003 | WO |
WO 03053287 | Jul 2003 | WO |
WO 03082153 | Oct 2003 | WO |
WO 03101518 | Dec 2003 | WO |
WO 04002365 | Jan 2004 | WO |
WO 04002370 | Jan 2004 | WO |
WO 04017867 | Mar 2004 | WO |
WO 04017868 | Mar 2004 | WO |
WO 04028399 | Apr 2004 | WO |
WO 2005034808 | Apr 2005 | WO |
WO 2005122962 | Dec 2005 | WO |
WO 2008002426 | Jan 2008 | WO |
WO 2008057568 | May 2008 | WO |
WO 2010111583 | Sep 2010 | WO |
WO 2011109067 | Sep 2011 | WO |
WO 2013104324 | Jul 2013 | WO |
WO 2013104324 | Aug 2013 | WO |
WO 2015071135 | May 2015 | WO |
WO 2015081175 | Jun 2015 | WO |
Entry |
---|
European Search Report for corresponding EP Application No. 18275052, dated Jun. 25, 2018, 7 pages. |
Huynh, T., “Remodeling Of An Acellular Collagen Graft Into A Physiologically Responsive Neovessel”, Nature America, Inc., Nature Biotechnology, vol. 17, Issue 11, Nov. 1999, pp. 1083-1086. |
Office Action received in related U.S. Appl. No. 10/962,765 dated Oct. 23, 2006, 11 pgs. |
Amendment and Response Office Action filed in related U.S. Appl. No. 10/962,765 dated Jan. 23, 2007, 10 pgs. |
Office Action received in related U.S. Appl. No. 10/962,765 dated Apr. 18, 2007, 10 pgs. |
Amendment and Response Office Action filed in related U.S. Appl. No. 10/962,765 dated Aug. 17, 2007, 8 pgs. |
Office Action received in related U.S. Appl. No. 10/962,765 dated Nov. 30, 2007, 12 pgs. |
Response to Final Office Action filed in related U.S. Appl. No. 10/962,765 dated Jan. 17, 2008, 7 pgs. |
Advisory Action received in related U.S. Appl. No. 10/962,765 dated Feb. 4, 2008, 3 pgs. |
Amendment and Response Following Advisory Action filed in related U.S. Appl. No. 10/962,765 dated Feb. 28, 2008, 10 pgs. |
Notice of Allowance received in related U.S. Appl. No. 10/962,765 dated Jun. 23, 2008, 9 pgs. |
Canada Office Action for related Canadian application No. CA 2,540,830, dated Oct. 28, 2010, 3 pgs. |
Japanese Grounds of Rejection for related Japanese application No. JP 534458/2006, dated Aug. 3, 2010, 4 pgs. |
Japanese Grounds of Rejection for related Japanese application No. JP 534458/2006, dated May 24, 2011, 5 pgs. |
International Search Report and Written Opinion for related PCT Application No. PCT/US2004/033568, dated Feb. 2, 2005, 8 pgs. |
Written Opinion of the International Preliminary Examining Authority for related PCT Application No. PCT/US2004/033568, dated Aug. 18, 2005, 5 pgs. |
International Preliminary Report on Patentability for related PCT Application No. PCT/US2004/033568, dated Feb. 9, 2006, 4 pgs. |
Office Action received for related U.S. Appl. No. 12/228,453 dated Jan. 3, 2011, 9 pgs. |
Response to Non-Final Office Action filed in related U.S. Appl. No. 12/228,453 dated Apr. 1, 2011, 6 pgs. |
Office Action received for related U.S. Appl. No. 12/228,453 dated May 5, 2011, 7 pgs. |
Preliminary Amendment Accompanying Request For Continued Examination filed in related U.S. Appl. No. 12/228,453, dated Oct. 5, 2011, 5 pgs. |
Office Action received for related U.S. Appl. No. 12/228,453 dated May 21, 2012, 12 pgs. |
Response to Non-Final Office Action filed in related U.S. Appl. No. 12/228,453 dated Oct. 22, 2012, 11 pgs. |
Supplemental Response to Non-Final Office Action and Interview Summary filed in related U.S. Appl. No. 12/228,453 dated Nov. 16, 2012, 13 pgs. |
Office Action received for related U.S. Appl. No. 12/228,453 dated Jan. 2, 2013, 2 pgs. |
Response to Non-Final Office Action filed in related U.S. Appl. No. 12/228,453 dated Feb. 4, 2013, 9 pgs. |
Office Action received for related U.S. Appl. No. 12/228,453 dated Mar. 21, 2013, 12 pgs. |
Pre-Appeal Conference Request filed in related U.S. Appl. No. 12/228,453 dated Jul. 22, 2013, 5 pgs. |
Pre-Appeal Conference Decision received in related U.S. Appl. No. 12/228,453 dated Aug. 13, 2013, 2 pgs. |
After Final Pilot Program Response filed in related U.S. Appl. No. 12/228,453, dated Nov. 22, 2013, 8 pgs. |
Advisory Action received for related U.S. Appl. No. 12/228,453 dated Dec. 18, 2013, 5 pgs. |
Office Action received for related U.S. Appl. No. 12/228,453 dated Feb. 20, 2014, 9 pgs. |
Amendment filed in related U.S. Appl. No. 12/228,453, dated May 19, 2014, 10 pgs. |
Applicant initiated Interview Summary received in related U.S. Appl. No. 12/228,453, dated Sep. 3, 2014, 4 pgs. |
Notice of Allowance in related U.S. Appl. No. 12/228,453, dated Nov. 4, 2014, 10 pgs. |
Amendment After Notice of Allowance (Rule 312) in related U.S. Appl. No. 12/228,453, filed Jan. 13, 2015, 8 pgs. |
Office Action received in related U.S. Appl. No. 13/759,461 dated Aug. 1, 2013, 12 pgs. |
Response to Non-Final Office Action filed in related U.S. Appl. No. 13/759,461 dated Dec. 2, 2013, 10 pgs. |
Office Action filed in related U.S. Appl. No. 13/759,461, dated Jan. 16, 2014, 12 pgs. |
Pre Appeal Conference Request filed in related U.S. Appl. No. 13/759,461 dated Apr. 16, 2014, 5 pgs. |
Pre-Appeal Conference Decision filed in related U.S. Appl. No. 13/759,461 dated May 9, 2014, 2 pgs. |
Interview Summary filed in related U.S. Appl. No. 13/759,461, dated Jul. 17, 2014, 3 pgs. |
Request for Examination and Amendment filed in related U.S. Appl. No. 13/759,461, dated Aug. 18, 2014, 10 pgs. |
Notice of Allowance filed in related U.S. Appl. No. 13/759,461, dated Sep. 18, 2014, 12 pgs. |
Office Action in related U.S. Appl. No. 13/950,975, dated Dec. 30, 2013, 10 pgs. |
Response to Non-Final Office Action filed in related U.S. Appl. No. 13/950,975, filed Apr. 30, 2014, 12 pgs. |
Final Office Action in related U.S. Appl. No. 13/950,975, dated Aug. 28, 2014, 10 pgs. |
Amendment filed in related U.S. Appl. No. 13/950,975, filed Jan. 20, 2015, 9 pgs. |
Notice of Allowance filed in related U.S. Appl. No. 13/950,975, dated Mar. 24, 2015, 8 pgs. |
Partial European Search Report for corresponding EP 15275213, dated Mar. 1, 2016, 4 pgs. |
Extended European Search Report for corresponding EP 15275213, dated May 30, 2016, 9 pgs. |
European Search Report for corresponding EP 17166079, dated May 11, 2017, 5 pgs. |
Examination Report for corresponding European Patent Application No. EP 17166079, dated Oct. 17, 2017, 6 pgs. |
Partial European Search Report for corresponding EP 15275213, dated Mar. 1, 2016, 4 pages. |
Extended European Search Report for corresponding EP 15275213, dated May 30, 2016, 9 pages. |
European Search Report for corresponding European Patent Application No. EP 17166079, dated May 11, 2017, 5 pages. |
Examination Report for corresponding European Patent Application No. EP 17166079, dated Oct. 17, 2017, 6 pages. |
European Search Report for EP Application No. 18168827.6 dated Jul. 16, 2018, 8 pages. |
European Examination Report for EP Application No. 18168827.6 dated Oct. 19, 2018, 6 pages. |
Number | Date | Country | |
---|---|---|---|
20180228594 A1 | Aug 2018 | US |
Number | Date | Country | |
---|---|---|---|
62487108 | Apr 2017 | US | |
62064595 | Oct 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14875925 | Oct 2015 | US |
Child | 15956034 | US |